Cytokinetics (CYTK) Misses Q4 EPS by 24c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $74.05 -1.73%
EPS Growth %: +43.1%
Financial Fact:
Net loss: 31.89M
Today's EPS Names:
SUNB, CULP, KFY, More
EPS Growth %: +43.1%
Financial Fact:
Net loss: 31.89M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q4 EPS of ($1.45), $0.24 worse than the analyst estimate of ($1.21). Revenue for the quarter came in at $1.96 million versus the consensus estimate of $7.45 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Core & Main, Inc (CNM) Tops Q3 EPS by 2c ; Offers Guidance
- BMO cautious on softlines, bearish on athletic names
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
